There were low expectations for the first film, and it exceeded those at the box office. There were still for some reason low expectations for the sequel, but again, it’s exceeded box office expectations with the highest pandemic-era opening in the U.S. at $90.1 million USD.
Venom: Let There Be Carnage has beaten Black Widow, Sang-Chi and the Legend of the Secret Rings, F9 and A Quiet Place Part II. The film’s $90.1 million earnings put it roughly $25 – $30 million USD above expectations.
The new film has also bested the original Venom which debuted at $80 million in 2018. In fact, the earnings look so good, that even a pre-pandemic film released at a similar time, like Joker, opened with a comparable $96 million. So the fact that Venom 2 can even get close to that during a pandemic is impressive and giving confidence to the industry for the future.
However, it should be noted that this is just for a U.S. released film, as neither the new James Bond film, No Time To Die, and sci-fi epic, Dune, have released in the U.S. or China yet. Those films have taken in huge numbers in other markets so it will be interesting to see whether or not those films can take the crown from Venom.
Critics have not been as kind to the film as audiences with just a middling 58% approval rating on Rotten Tomatoes. The consensus reads, “A sequel aimed squarely at fans of the original’s odd couple chemistry, Venom: Let There Be Carnage eagerly embraces the franchise’s sillier side.”
Audience reviews are much kinder with an 85% approval rating. The audience consensus reads, “With tons of action, fun fight scenes, and plenty of comedy, Venom: Let There Be Carnage gives fans everything they’ll be looking for — plus a can’t-miss post-credits surprise.”
The Tom Hardy led film will be released in Australia on November 11 once everything is opened up once again.